Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients
Clinical trial NCT00525031 · COMPLETED
Trial details
- NCT number
- NCT00525031
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2016-06-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.